Free Trial
→ Has Trump finally met his match? (From Behind the Markets) (Ad)

Can These 3 Healthcare Dividend Stocks Deliver Income Growth?

Kate Stalter
Written by Kate Stalter
September 18, 2023

Key Points

  • S&P 500 components Pfizer Medtronic and Gilead are undervalued dividend stocks from the healthcare sector.
  • All three have a history of increasing their dividends.
  • The healthcare sector historically does well during bouts of economic sluggishness, which bodes well for income investors. 
  • Five stocks we like better than Gilead Sciences.
Remove Ads

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Upgrade Now See Benefits

Already have an account? Log in here.

Should You Invest $1,000 in Gilead Sciences Right Now?

Before you consider Gilead Sciences, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Gilead Sciences wasn't on the list.

While Gilead Sciences currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover
A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Kate Stalter
About The Author

Kate Stalter

Contributing Author

Retirement, Asset Allocation, and Tax Strategies

Learn More about Kate Stalter
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Gilead Sciences (GILD)
4.5837 of 5 stars		$111.79+0.6%2.83%302.14Moderate Buy$105.12
Medtronic (MDT)
4.4199 of 5 stars		$87.62-1.5%3.20%26.63Hold$96.07
Pfizer (PFE)
4.9866 of 5 stars		$25.20+0.8%6.83%17.87Moderate Buy$31.92
Eli Lilly and Company (LLY)
4.8028 of 5 stars		$820.30-0.2%0.73%70.05Moderate Buy$1,009.72
Compare These Stocks  Add These Stocks to My Watchlist 

Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads